Ebola trial candidate vaccines arrived in Uganda in record 79 days after outbreak declared
On Dec. 9, 2022, the World Health Organization (WHO) announced that the first doses of one of the…
FDA granted approval to atezolizumab for alveolar soft part sarcoma
On Dec. 9, 2022, the U.S. Food and Drug Administration (FDA) approved Genentech’s atezolizumab (Tecentriq) for adult and…
Biotechnology | COVID-19 | Life Science News | Therapeutics | Vaccine | WHO
Novavax Nuvaxovid COVID-19 vaccine approved in Canada for use as a primary series in adolescents
On Dec. 7, 2022, Novavax announced that Health Canada had approved a supplement to a New Drug Submission…
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Life Science News | Therapeutics | Vaccine
Hutchinson Cancer Center leads large-scale review of COVID-19 clinical trials that highlights multiple disparities
On Dec. 5, 2022, the Fred Hutchinson Cancer Center announced that according to a new meta-analysis women were…
FDA approved first gene therapy to treat adults with Hemophilia B
On Nov. 22, 2022, the U.S. Food and Drug Administration approved the investigational gene therapy etranacogene dezaparvovec or…
FDA approved first drug that can delay onset of Type 1 Diabetes
On Nov. 17, 2022, the U.S. Food and Drug Administration (FDA) approved Tzield (teplizumab-mzwv) injection to delay the…
Biotechnology | Diagnostics | Life Science News | Non-Profit Research | Oncology | Therapeutics | Vaccine
CPRIT approved $12 million to bring top-flight cancer researchers to Lone Star State
On Nov. 16, 2022, the Cancer Prevention and Research Institute of Texas (CPRIT) approved $12 million in recruitment…
Biotechnology | Diagnostics | Disease | Life Science News | Neurology | NIH | Therapeutics
NIH researchers unlocked pattern of gene activity for ADHD
On Nov. 16, 2022, resarchers at the National Institutes of Health (NIH) announced they had successfully identified differences…
Moderna’s BA.4/BA.5 targeting bivalent booster, mRNA-1273.222, met primary endpoint of superiority against omicron variants
On Nov. 14, 2022, Moderna announced that both of Moderna’s bivalent Omicron-targeting booster candidates (mRNA-1273.214 and mRNA-1273.222) trigger…
Researchers identified a pathway by which chronic hyperglycaemia reduces cell function
On Nov. 14, 2022, researchers discovered the pathway by which chronic hyperglycaemia reduces β-cell function. Their data also…
Novavax Nuvaxovid COVID-19 Vaccine authorized in the United Kingdom for use as a booster in adults
On Nov. 9, 2022, Novavax announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in the United…
First ever clinical trial of laboratory grown red blood cells being transfused into another person
On Nov. 7, 2022, the NHS Blood and Transplant (NHSBT) reported that red blood cells grown in a…
Biotechnology | COVID-19 | Diagnostics | Disease | Life Science News | NIH | Therapeutics
NIH-funded study showed blood pressure levels rose during pandemic
On Nov. 1, 2022, the National Institutes of Health (NIH) announced that adults with hypertension saw a small,…
Biotechnology | Diagnostics | Disease | Life Science News | NIH | Oncology | Therapeutics
Reported cancer deaths continued downward trend; modest improvements in survival for pancreatic cancer
On Oct. 27, 2022, the National Institutes of Health (NIH) announced that overall cancer death rates continued to…
Karmanos completed $48 million expansion at Farmington Hills cancer center
On Oct. 26, 2022, the Barbara Ann Karmanos Cancer Institute announced it had completed an over 50,000-square-foot expansion…
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Life Science News | Nanotechnology | Therapeutics | Vaccine
COVID-causing virus in air detected with high-tech bubbles
On Oct. 25, 2022, Pacific Northwest National Laboratory (PNNL) announced that scientists have shown that they can detect…
FDA finalized historic rule enabling access to Over-the-Counter hearing aids for millions of Americans
On Oct. 19, 2022, the U.S. Food and Drug Administration final rule establishing Over-the-Counter Hearing Aids to improve…
Pfizer and BioNTech announced positive early data from clinical trial of Omicron BA.4/BA.5-adapted bivalent booster
On Oct. 13, 2022, Pfizer and BioNTech announced early data from a Phase 2/3 clinical trial (NCT05472038) evaluating…
Hutchinson Cancer Center announced $710.5 million gift to support cancer and infectious disease research, ‘skin-on-chip’ technology
On Oct. 12, 2022, the Fred Hutchinson Cancer Center (FHCRC) announced the Bezos family had committed $710.5 million…
Mayo Clinic received $100 million gift from Fred C. and Katherine B. Andersen Foundation to expand proton beam therapy services
On Oct. 10, 2022, the Mayo Clinic announced that The Fred C. and Katherine B. Andersen Foundation of…
Biotechnology | COVID-19 | Infectious Disease | Life Science News | Pharmaceutical | Therapeutics | Vaccine
Pfizer and BioNTech’s Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine booster received Health Canada authorization for individuals 12 years of age and older
On Oct. 7, 2022, Pfizer and BioNTech announced that Health Canada had authorized COMIRNATY Original & Omicron BA.4/BA.5…
Biotechnology | Diagnostics | Disease | Genomics | Life Science News | NIH | Therapeutics
NIH established initiative to systematically investigate and establish function of every human gene
On Sept. 27, 2022, the National Institutes of Health (NIH) announced it had launched a program to better…
Pfizer to supply global fund up to 6 million PAXLOVID treatment courses for low-and-middle-income countries
On Supt. 22, 2022, Pfizer announced an agreement to supply up to six million treatment courses of its…
Biotechnology | Cartoons - Original | CRISPR | Disease | Genomics | Life Science History | Therapeutics | U.S. Congress | Vaccine
U.S. Biotechnology & Biomanufacturing Initiative
On Sept. 14, 2022, The U.S. Biotech Initiative was announced detailing new investments and resources to advance the…
Fred Hutchinson Cancer Center received $78 million gift to support precision oncology
On Sept. 8, 2022, the Fred Hutchinson Cancer Center (FHCRC) announced that Stuart and Molly Sloan had pledged…
FDA Approved Daxxify, a New Anti-Wrinkle Drug
On Sept. 7, 2022, the U.S. Food and Drug Administration (FDA) announced it had approved Revance Therapeutics’ DAXXIFY…
$838 Million neurosciences center broke ground in Connecticut
On Aug. 31, 2022, the Yale New Haven Hospital broke ground on the $838 million, 505,000 square foot…
Pfizer and BioNTech completed submission to EMA for Omicron BA.4/BA.5 adapted bivalent vaccine
On Aug. 26, 2022, Pfizer and BioNTech announced they had completed a submission to the European Medicines Agency…
Roche announced U.S. FDA approval of Xofluza to treat influenza in children aged five years and older
On Aug. 11, 2022, Roche announced that the U.S. Food and Drug Administration (FDA) had approved a supplemental…
Biotechnology | Diagnostics | Disease | Life Science News | Oncology | Radiology | Therapeutics | Women's Health
FDA approved first targeted therapy for HER2-low breast cancer
On Aug. 5, 2022, the U.S. Food and Drug Administration (FDA) approved Daiichi Sankyo’s Enhertu (fam-trastuzumab-deruxtecan-nxki), an IV…